Total planned funding: $313,768,277
Clear active filters
University
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
| Kenya | $60,456,971 |
| Mozambique | $56,526,594 |
| Tanzania | $39,007,548 |
| Uganda | $33,109,863 |
| South Africa | $19,937,462 |
| Malawi | $19,768,508 |
| Ethiopia | $18,271,520 |
| Côte d'Ivoire | $11,107,266 |
| Haiti | $9,560,512 |
| Democratic Republic of the Congo | $8,530,794 |
| Angola | $4,715,000 |
| Nigeria | $4,305,100 |
| Zambia | $4,079,000 |
| Rwanda | $3,683,890 |
| South Sudan | $3,300,000 |
| Vietnam | $2,804,035 |
| Zimbabwe | $2,475,000 |
| Namibia | $2,180,000 |
| Eswatini | $2,000,000 |
| Botswana | $1,924,876 |
| Cameroon | $1,740,000 |
| Central Asia Region | $1,051,915 |
| Ukraine | $1,050,000 |
| India | $900,000 |
| Lesotho | $673,904 |
| Caribbean Region | $300,000 |
| Guyana | $258,519 |
| Asia Regional Program | $50,000 |
| Dominican Republic | $0 |
| Ghana | $0 |
| Central America Region | $0 |
Organizational Types
| University | $313,768,277 |
Program Areas
| Treatment | $106,685,661 |
| Prevention | $76,033,420 |
| Governance and Systems | $65,969,656 |
| Care | $49,877,446 |
| Testing | $15,202,094 |
Budget Codes
| HTXS: Treatment: Adult Treatment | $91,330,106 |
| HVSI: Strategic Information | $38,683,712 |
| MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $32,647,611 |
| CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $28,173,443 |
| OHSS: Health Systems Strengthening | $21,521,768 |
| HBHC: Care: Adult Care and Support | $20,214,949 |
| PDTX: Treatment: Pediatric Treatment | $15,355,555 |
| HVCT: Testing: HIV Testing and Counseling | $15,202,094 |
| HVTB: Care: TB/HIV | $12,343,993 |
| HVOP: Sexual Prevention: Other Sexual Prevention | $11,336,259 |
| PDCS: Care: Pediatric Care and Support | $9,758,075 |
| HKID: Care: Orphans and Vulnerable Children | $7,560,429 |
| HLAB: Laboratory Infrastructure | $5,764,176 |
| IDUP: Prevention: Injecting and Non-Injecting Drug Use | $2,415,800 |
| HMIN: Biomedical Prevention: Injection Safety | $701,813 |
| HVAB: Sexual Prevention: Abstinence/Be Faithful | $432,263 |
| HMBL: Biomedical Prevention: Blood Safety | $326,231 |
| HTXD: Treatment: ARV Drugs | $0 |